Antidepressants in Inflammatory Bowel Disease: A Systematic Review

@article{Macer2017AntidepressantsII,
  title={Antidepressants in Inflammatory Bowel Disease: A Systematic Review},
  author={Benjamin Macer and S. Prady and A. Mikocka-Walus},
  journal={Inflammatory Bowel Diseases},
  year={2017},
  volume={23},
  pages={534–550}
}
Background: Antidepressants are commonly used to treat symptoms of anxiety and depression in inflammatory bowel disease (IBD. [...] Key Method Results: Fifteen eligible studies included in the review (1 randomized controlled trial, 2 cohorts, 1 case–control, 1 cross-sectional survey, 1 qualitative, 2 audits, 1 case series, and 6 case reports) examined a range of antidepressants. Twelve studies suggested that antidepressants have a positive impact on IBD course. Nine studies reported anxiety and depression as…Expand
View on Wolters Kluwer
academic.oup.com
35 Citations
Background Citations
7

Paper Mentions

Interventional Clinical Trial
Group Cognitive Behavioral Therapy for IBD Patients
Inflammatory bowel disease (IBD) patients commonly suffer from disturbed psychosocial functioning and poor quality of life compared to other chronic disease patients. Clinicians… Expand
ConditionsInflammatory Bowel Diseases
InterventionBehavioral
University Hospital of Patras
February 2019 - October 2021
News Article
The brain and the gut talk to each other. This is how fixing one could help the other
Scroll India
20 July 2017
Blog Post
The brain and the gut talk to each other
Guest Work
17 July 2017

35 Citations

Citation Type

Citation Type

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
TLDR
The efficacy and safety of antidepressants for treating anxiety and depression in IBD, and the effects of antidepressants on quality of life (QoL) and managing disease activity in I BD are assessed. Expand
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review.
TLDR
The results suggest that psychiatric treatment should be implemented in IBD care, however, further studies are needed to confirm the findings of this systematic review. Expand
The Effect of Antidepressants on the Course of Inflammatory Bowel Disease
TLDR
Antidepressants may have some beneficial effects on the natural history of IBD, but larger studies with longer follow-up are required to determine whether these effects are limited to patients with abnormal mood. Expand
Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
TLDR
The evidence suggests that adverse effects may be common in patients with IBD treated with antidepressants, creating an important barrier to mental and physical recovery from anxiety, depression, and their potential sequelae. Expand
Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression
TLDR
Patients with a history of depression were more likely to be diagnosed with IBD and antidepressant treatments were selectively protective for Crohn’s disease and UC, which may impact counselling and management of depression and IBD. Expand
The emerging role of mood disorders in inflammatory bowel diseases.
TLDR
Monitoring for mood disorders should become a part of the multi-disciplinary and holistic approach to patients with IBD, based on current literature searched in PubMed. Expand
The Influence of Antidepressants on the Disease Course Among Patients With Crohn’s Disease and Ulcerative Colitis—A Danish Nationwide Register–Based Cohort Study
TLDR
In this nationwide study, antidepressant use was found to be beneficial on the disease course among patients with UC and CD, particularly in patients with no use of antidepressants before IBD onset. Expand
The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.
TLDR
Symptoms of depression and anxiety are associated with disease activity in IBD over time and reducing these symptoms should be incorporated into the management of IBD. Expand
Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation?
TLDR
This study goes further, suggesting that assertive pharmacological treatment of depression could reduce the incidence of IBD altogether, and draws the authors’ attention to an important limitation of its current design that tempers its conclusions. Expand
Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist
TLDR
Despite the significant limitations of research, particularly lack of clinical trials examining behavioral and pharmacotherapy interventions in IBD, effective treatments exist and are best utilized in an integrated care setting. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 44 REFERENCES
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
TLDR
The efficacy and safety of antidepressants for treating anxiety and depression in IBD, and the effects of antidepressants on quality of life (QoL) and managing disease activity in I BD are assessed. Expand
Can antidepressants influence the course of inflammatory bowel disease? The current state of research
TLDR
Overall, the studies suggest a positive impact of antidepressants on inflammation in IBD, however, good-quality human data are lacking and more RCTs are needed. Expand
Antidepressants and inflammatory bowel disease: a systematic review
TLDR
Although most of reviewed papers suggest a beneficial effect of treatment with antidepressants in patients with IBD, due to the lack of reliable data, it is impossible to judge the efficacy of antidepressants in IBD. Expand
Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases
TLDR
The high rates of anxiety and depression for those with IBD, particularly when disease is active, warrant a systemic approach to screening and treatment. Expand
Do Antidepressants Influence the Disease Course in Inflammatory Bowel Disease? A Retrospective Case‐Matched Observational Study
TLDR
Antidepressants, when used to treat concomitant mood disorders in IBD, seem to reduce relapse rates, use of steroids, and endoscopies in the year after their introduction, suggesting the need for a prospective controlled trial to evaluate their effects on disease course in patients with IBD. Expand
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
TLDR
Antidepressants are effective in the treatment of IBS and there is less high-quality evidence for routine use of psychological therapies in IBS, but available data suggest these may be of comparable efficacy. Expand
The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit.
TLDR
Antidepressants are commonly prescribed in IBD patients and appear to be mostly used for functional symptoms, but the current data do not allow us to judge whether they improve IBD disease activity. Expand
Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
TLDR
Antidepressants and some psychological therapies are effective treatments for IBS, and summary estimates of treatment effect have remained remarkably stable since the previous meta-analysis. Expand
A magic pill? A qualitative analysis of patients’ views on the role of antidepressant therapy in inflammatory bowel disease (IBD)
TLDR
Antidepressants seem to be well tolerated by IBD patients and the positive attitude towards antidepressants in these participants may make the conduct of clinical trials to further assess for any specific role on IBD course feasible. Expand
Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease
TLDR
In a clinical practice setting, TCA use led to moderate improvement of residual gastrointestinal symptoms in IBD patients for whom escalation of IBD therapy was not planned. Expand
...
1
2
3
4
5
...